5. Market Dynamics
5.1 Drivers
5.1.1 Rising Incidences of Chronic Diseases
5.1.2 Surging Demand for High-Content Screening Techniques
5.1.3 Increasing Funding Support by Public and Private Sector
5.1.4 Availability of Long-term Live Cell Imaging Platform
5.1.5 Live Cell Imaging Instruments Accelerating Drug Discovery
5.2 Challenges
5.2.1 Maintaining Live Cells on Microscope Stage
5.2.2 Mimicking the In Vivo Microenvironment
5.2.3 Lack of Awareness
5.3 Opportunities
5.3.1 Adoption of High Content Screening Systems for Primary Screening
5.3.2 Application of In Vivo Live Cell Imaging Techniques
6. Global Live Cell Imaging Market By Product
6.1 Equipment
6.2 Consumables
6.3 Software
7. Global Live Cell Imaging Market by Application
7.1 Cell Biology
7.2 Developmental Biology
7.3 Stem Cell Biology
7.4 Drug Discovery
7.5 Other Applications
8. Global Live Cell Imaging Market By Technology
8.1 Fluorescent Resonance Energy Transfer (FRET)
8.2 High Content Analysis (HCA)
8.3 Fluorescence In Situ Hybridization (FISH)
8.4 Other Technologies
9. Global Live Cell Imaging Market By Geography
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Rest of the World
10. Trends & Developments
10.1 Fluorescent Probes Enriching Live Cell Imaging
10.2 Introduction of LiveCyte Kinetic Cytometer for Label-free, Quantitative Phase Imaging
10.3 Live Cell Imaging Revealing Intracellular Interactions
10.4 Introduction of Single Plane Illumination Microscopy Advancing Live Cell Imaging
11. Mergers & Other Collaborations
12. Company Profiles
12.1 Carl Zeiss GmbH
12.2 Becton Dickenson & Co.
12.3 Olympus Corporation
12.4 ThermoFisher Scientific Inc.
12.5 Merck KGaA
12.6 PerkinElmer, Inc.
12.7 Nikon Instruments Inc.
12.8 GE Healthcare
12.9 Lonza
12.10 Danaher Corporation